The Use of an Electronic Nose to Distinguish Between Bacterial and Non-Bacterial Exacerbations of Chronic Obstructive Pulmonary Disease.
Not Applicable
Recruiting
- Conditions
- Chronic obstructive pulmonary disease (COPD)Respiratory - Chronic obstructive pulmonary disease
- Registration Number
- ACTRN12611000624987
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Diagnosed COPD
Exclusion Criteria
Forced Expiratory Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) percentage (FEV1/FVC) greater than 70%
(FEV1) less than 40% predicted
Other significant pulmonary disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in electronic nose output for active AECOPD and stable controls (internal and external) by statistical analysis[4 weeks after electronic nose analysis]
- Secondary Outcome Measures
Name Time Method Difference in electronic nose output between bacterial and viral associated exacerbations, by standard statistical analysis[4 weeks as above.]